Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pain - Trial NCT06229470
Access comprehensive clinical trial information for NCT06229470 through Pure Global AI's free database. This phase not specified trial is sponsored by Saluda Medical Pty Ltd and is currently Recruiting. The study focuses on Chronic Pain. Target enrollment is 250 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Saluda Medical Pty Ltd
Timeline & Enrollment
N/A
Mar 08, 2024
Feb 28, 2027
Primary Outcome
Change in Evoked Compound Action Potentials (ECAPs) as measured by the Evoke SCS System
Summary
The purpose of this study is to evaluate the clinical utility of neurophysiological
 measurements of ECAP-controlled closed-loop SCS (i.e., neural panel metrics) to guide
 treatment of chronic pain of the trunk and/or limbs.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06229470
Device Trial